Publikationen

 

 

Publikationen Univ.-Klinik Gynäkologie u. Geburtshilfe 2019

 

(alle älteren Publikationen finden Sie über einschlägigen Suchmaschinen wie PubMed oder über die Homepage der Universitäts- und Landesbibliothek Tirol)

2019

  1. Bjelic-Radisic, Vesna; Singer, Christian; Tamussino, Karl; Koelbl, Heinz; Petru, Edgar; Volgger, Birgit; Polterauer, Stephan; Oppelt, Peter; Sevelda, Paul; Bogner, Gerhard; Marth, Christian; Austrian Gynecologic Oncology Work: Contralateral prophylactic mastectomy in women with breast cancer without afamily history or genetic predisposition: Consensus statement from the Austrian Gynecologic Oncology Working Group of the Austrian Society of Obstetrics and Gynecology.
    WIENER KLINISCHE WOCHENSCHRIFT. 2019; 131(9-10); 233-236.
    PubMed: 30887224 doi: 10.1007/s00508-019-1468-7 [FLDID: 126805] IF: 1.170 (2018) / ZIT: 0
  2. Canazei, Markus; Pohl, Wilfried; Weninger, Johannes; Bliem, Harald; Weiss, Elisabeth M.; Koch, Christiane; Berger, Astrid; Firulovic, Branka; Marth, Christian: Effects of adjustable dynamic bedroom lighting in a maternity ward.
    JOURNAL OF ENVIRONMENTAL PSYCHOLOGY. 2019; 62(S); 59-66.
    doi: 10.1016/j.jenvp.2019.01.010 [FLDID: 126730] IF: 3.626 (2018) / ZIT: 0
  3. Colombo, N.; Sessa, C.; du Bois, A.; Ledermann, J.; McCluggage, W. G.; McNeish, I.; Morice, P.; Pignata, S.; Ray-Coquard, I.; Vergote, I.; Baert, T.; Belaroussi, I.; Dashora, A.; Olbrecht, S.; Planchamp, F.; Querleu, D.; Baert, T.; Banerjee, S.; Belaroussi, I.; Blecharz, P.; Bruchim, I.; Cibula, D.; Colombo, N.; Concin, N.; Davidson, B.; Dashora, A.; Devouassoux-Shisheboran, M.; du Bois, A.; Ferrero, A.; Glasspool, R.; Gonzalez-Martin, A.; Heinzelmann-Schwarz, V.; Joly, F.; Kim, J. W.; Kridelka, F.; Ledermann, J.; Lorusso, D.; Mahner, S.; McCluggage, W. G.; McNeish, I.; Mikami, M.; Mirza, M. R.; Morice, P.; Nicum, S.; Olbrecht, S.; O'Donnell, D. M.; Pautier, P.; Planchamp, F.; Pignata, S.; Querleu, D.; Ray-Coquard, I.; Rodolakis, A.; Sehouli, J.; Selcukbiricik, F.; Sessa, C.; Singh, N.; Tan, D. S. P.; Timmerman, D.; Tognon, G.; van der Velden, J.; Vergote, I.; Witteveen, P. O.; Zeimet, A. G.; ESMO-ESGO Ovarian Canc Consensus: ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.
    ANNALS OF ONCOLOGY. 2019; 30(5); 672-705.
    PubMed: 31046081 doi: 10.1093/annonc/mdz062 [FLDID: 126776] IF: 14.196 (2018) / ZIT: 20
  4. Colombo, N.; Sessa, C.; du Bois, A.; Ledermann, J.; McCluggage, W. G.; McNeish, I.; Morice, P.; Pignata, S.; Ray-Coquard, I.; Vergote, I.; Baert, T.; Belaroussi, I.; Dashora, A.; Olbrecht, S.; Planchamp, F.; Querleu, D.; Banerjee, S.; Blecharz, P.; Bruchim, I.; Cibula, D.; Concin, N.; Davidson, B.; Devouassoux-Shisheboran, M.; Ferrero, A.; Glasspool, R.; Gonzalez-Martin, A.; Heinzelmann-Schwarz, V.; Joly, F.; Kim, J. W.; Kridelka, F.; Lorusso, D.; Mahner, S.; Mikami, M.; Mirza, M. R.; Nicum, S.; O'Donnell, D. M.; Pautier, P.; Rodolakis, A.; Sehouli, J.; Selcukbiricik, F.; Singh, N.; Tan, D. S. P.; Timmerman, D.; Tognon, G.; van der Velden, J.; Witteveen, P. O.; Zeimet, A. G.; ESMO-ESGO Ovarian Canc Consensus: ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019; 29(4); 728-760.
    PubMed: 31048403 doi: 10.1136/ijgc-2019-000308 [FLDID: 126554] IF: 1.746 (2018) / ZIT: 4
  5. Coosemans, A.; Vankerckhoven, A.; Baert, T.; Boon, L.; Ruts, H.; Riva, M.; Blagden, S.; Delforge, M.; Concin, N.; Mirza, M. R.; Ledermann, J. A.; du Bois, A.; Vergote, I: Combining conventional therapy with immunotherapy: A risky business?
    EUROPEAN JOURNAL OF CANCER. 2019; 113(S); 41-44.
    PubMed: 30965214 doi: 10.1016/j.ejca.2019.02.014 [FLDID: 126649] IF: 6.680 (2018) / ZIT: 3
  6. Dalla Torre, Daniel; Burtscher, D.; Soelder, E.; Rasse, M.; Puelacher, W.: The correlation between the quality of oral hygiene and oral HPV infection in adults: a prospective cross-sectional study.
    CLINICAL ORAL INVESTIGATIONS. 2019; 23(1); 179-185.
    PubMed: 29574499 doi: 10.1007/s00784-018-2425-y [FLDID: 126762] IF: 2.453 (2018) / ZIT: 2
  7. (•) Degasper, Christine; Brunner, Andrea; Sampson, Natalie; Tsibulak, Irina; Wieser, Verena; Welponer, Hannah; Marth, Christian; Fiegl, Heidi; Zeimet, Alain Gustave: NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer.
    TUMOR BIOLOGY. 2019; 41(2); 1010428319830002.
    PubMed: 30813866 doi: 10.1177/1010428319830002 [FLDID: 127504] IF: 3.650 (2016) / ZIT: 0
  8. (κ) Garcia-Etienne, CA.; Mansel, RE.; Tomatis, M.; Heil, J.; Biganzoli, L.; Ferrari, A.; Marotti, L.; Sgarella, A.; Ponti, A.; EUSOMA Working Group [Egle, D.]: Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice.
    BREAST. 2019; 45(S); 89-96.
    PubMed: 30925382 doi: 10.1016/j.breast.2019.03.002 [FLDID: 127054] IF: 3.494 (2018) / ZIT: 3
  9. Gnant, Michael; Pfeiler, Georg; Steger, Guenther G.; Egle, Daniel; Greil, Richard; Fitzal, Florian; Wette, Viktor; Balic, Marija; Haslbauer, Ferdinand; Melbinger-Zeinitzer, Elisabeth; Bjelic-Radisic, Vesna; Jakesz, Raimund; Marth, Christian; Sevelda, Paul; Mlineritsch, Brigitte; Exner, Ruth; Fesl, Christian; Frantal, Sophie; Singer, Christian F.; Austrian Breast Colorectal Canc St: Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    LANCET ONCOLOGY. 2019; 20(3); 339-351.
    PubMed: 30795951 doi: 10.1016/S1470-2045(18)30862-3 [FLDID: 126496] IF: 35.386 (2018) / ZIT: 21
  10. Guan, Jun; Darb-Esfahani, Silvia; Richter, Rolf; Taube, Eliane T.; Ruscito, Ilary; Mahner, Sven; Woelber, Linn; Prieske, Katharina; Concin, Nicole; Vergote, Ignace; Van Nieuwenhuysen, Els; Achimas-Cadariu, Patriciu; Glajzer, Joanna; Woopen, Hannah; Stanske, Mandy; Kulbe, Hagen; Denkert, Carsten; Sehouli, Jalid; Braicu, Elena Ioana: Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2019; 145(4); 1063-1073.
    PubMed: 30810838 doi: 10.1007/s00432-019-02877-4 [FLDID: 126115] IF: 3.332 (2018) / ZIT: 0
  11. Harter, Philipp; Sehouli, Jalid; Lorusso, Domenica; Reuss, Alexander; Vergote, Ignace; Marth, Christian; Kim, Jae-Weon; Raspagliesi, Francesco; Lampe, Bjoern; Aletti, Giovanni; Meier, Werner; Cibula, David; Mustea, Alexander; Mahner, Sven; Runnebaum, Ingo B.; Schmalfeldt, Barbara; Burges, Alexander; Kimmig, Rainer; Scambia, Giovanni; Greggi, Stefano; Hilpert, Felix; Hasenburg, Annette; Hillemanns, Peter; Giorda, Giorgio; von Leffern, Ingo; Schade-Brittinger, Carmen; Wagner, Uwe; du Bois, Andreas: A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.
    NEW ENGLAND JOURNAL OF MEDICINE. 2019; 380(9); 822-832.
    PubMed: 30811909 doi: 10.1056/NEJMoa1808424 [FLDID: 126594] IF: 70.670 (2018) / ZIT: 30
  12. (•) Hatina, Jiri; Boesch, Maximilian; Sopper, Sieghart; Kripnerova, Michaela; Wolf, Dominik; Reimer, Daniel; Marth, Christian; Zeimet, Alain G.: Ovarian Cancer Stem Cell Heterogeneity.
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 2019; 1139(S); 201-221.
    PubMed: 31134503 doi: 10.1007/978-3-030-14366-4_12 [FLDID: 126526] IF: 2.126 (2018) / ZIT: 1
  13. Johnsson, Vilma L.; Pedersen, Nina G.; Worda, Katharina; Krampl-Bettelheim, Elisabeth; Skibsted, Lillian; Hinterberger, Stefan; Strobl, Isolde; Bowman, Maria E.; Smith, Roger; Tabor, Ann; Rode, Line: Plasma progesterone, estradiol, and unconjugated estriol concentrations in twin pregnancies: Relation with cervical length and preterm delivery.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2019; 98(1); 86-94.
    PubMed: 30218572 doi: 10.1111/aogs.13464 [FLDID: 126228] IF: 2.741 (2018) / ZIT: 2
  14. Lorusso, Domenica; Hilpert, Felix; Gonzalez Martin, Antonio; Rau, Joern; Ottevanger, Petronella; Greimel, Elfriede; Lueck, Hans-Joachim; Selle, Frederic; Colombo, Nicoletta; Kroep, Judith R.; Mirza, Mansoor R.; Berger, Regina; Pardo, Beatriz; Grischke, Eva-Maria; Berton-Rigaud, Dominique; Martinez-Garcia, Jeronimo; Vergote, Ignace; Redondo, Andres; Cardona, Andres; Bastiere-Truchot, Lydie; du Bois, Andreas; Kurzeder, Christian; del Campo, J. M.; Bover, I.; Barretina-Ginesta, P.; Ortega, E.; Garcia, Y.; Romero, I.; Poveda, A.; Herrero, A.; Vidal, L.; Rubio, M. J.; Romeo, M.; Mendiola, C.; Arranz, J. A.; Santaballa, A.; Gomez de Liano, A.; Marme, F.; Mahner, S.; Canzler, U.; Zorr, A.; Gropp-Meier, M.; Cayir, P.; Schmalfeldt, B.; Rautenberg, B.; Meier, W.; Belau, A.; Gerber, B.; Rein, D.; Jackisch, C.; Janni, W.; Heubner, M.; Pautier, P.; Fabbro, M.; Floquet, A.; You, B.; Favier, L.; Joly, F.; Weber, B.; Hardy-Bessard, A. -C.; Gadducci, A.; Tognon, G.; DeCensi, A.; Savarese, A.; Pisano, C.; Sonke, G.; Reyners, A.; Kristensen, G.; Bjurberg, M.; Rosenberg, P.; Marth, C.; PENELOPE Trial Investigators: Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019; 29(7); 1141-1147.
    PubMed: 31420414 doi: 10.1136/ijgc-2019-000370 [FLDID: 126578] IF: 1.746 (2018) / ZIT: 0
  15. Mayer, Ingrid A.; Prat, Aleix; Egle, Daniel; Blau, Sibel; Perez Fidalgo, J. Alejandro; Gnant, Michael; Fasching, Peter A.; Colleoni, Marco; Wolff, Antonio C.; Winer, Eric P.; Singer, Christian F.; Hurvitz, Sara; Garcia Estevez, Laura; van Dam, Peter A.; Kuemmel, Sherko; Mundhenke, Christoph; Holmes, Frankie; Babbar, Naveen; Charbonnier, Laure; Diaz-Padilla, Ivan; Vogl, Florian D.; Sellami, Dalila; Arteaga, Carlos L.: A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB).
    CLINICAL CANCER RESEARCH. 2019; 25(10); 2975-2987.
    PubMed: 30723140 doi: 10.1158/1078-0432.CCR-18-3160 [FLDID: 126311] IF: 8.911 (2018) / ZIT: 10
  16. Piovano, Elisa; Ferrero, Annamaria; Zola, Paolo; Marth, Christian; Mirza, Mansoor Raza; Lindemann, Kristina: Clinical pathways of recovery after surgery for advanced ovarian/tubal/peritoneal cancer: an NSGO-MaNGO international survey in collaboration with AGOa focus on surgical aspects.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019; 29(1); 181-187.
    PubMed: 30640702 doi: 10.1136/ijgc-2018-000021 [FLDID: 126880] IF: 1.746 (2018) / ZIT: 2
  17. Preyer, Oliver; Husslein, Heinrich; Concin, Nicole; Ridder, Anna; Musielak, Maciej; Pfeifer, Christian; Oberaigner, Willi; Husslein, Peter: Fetal weight estimation at term - ultrasound versus clinical examination with Leopold's manoeuvres: a prospective blinded observational study.
    BMC PREGNANCY AND CHILDBIRTH. 2019; 19(S); 122.
    PubMed: 30971199 doi: 10.1186/s12884-019-2251-5 [FLDID: 126597] IF: 2.413 (2018) / ZIT: 1
  18. Ray-Coquard, I.; Pautier, P.; Pignata, S.; Pérol, D.; González-Martín, A.; Berger, R.; Fujiwara, K.; Vergote, I.; Colombo, N.; Mäenpää, J.; Selle, F.; Sehouli, J.; Lorusso, D.; Guerra Alía, EM.; Reinthaller, A.; Nagao, S.; Lefeuvre-Plesse, C.; Canzler, U.; Scambia, G.; Lortholary, A.; Marmé, F.; Combe, P.; de Gregorio, N.; Rodrigues, M.; Buderath, P.; Dubot, C.; Burges, A.; You, B.; Pujade-Lauraine, E.; Harter, P.; PAOLA-1 Investigators [Marth, C.]: Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
    NEW ENGLAND JOURNAL OF MEDICINE. 2019; 381(25); 2416-2428.
    PubMed: 31851799 doi: 10.1056/NEJMoa1911361 [FLDID: 127298] IF: 70.670 (2018) / ZIT: 3
  19. (•) Ray-Coquard, Isabelle; Braicu, Ioana; Berger, Regina; Mahner, Sven; Sehouli, Jalid; Pujade-Lauraine, Eric; Cassier, Philippe Alexandre; Moll, Ute Martha; Ulmer, Hanno; Leunen, Karin; Zeimet, Alain Gustave; Marth, Christian; Vergote, Ignace; Concin, Nicole; GANNET53 Consortium 18 Partner Ins: Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium.
    FRONTIERS IN ONCOLOGY. 2019; 9(S); 832.
    PubMed: 31552170 doi: 10.3389/fonc.2019.00832 [FLDID: 126835] IF: 4.137 (2018) / ZIT: 0
  20. Rocamora-Reverte, Lourdes; Tuzlak, Selma; von Raffay, Laura; Tisch, Marcel; Fiegl, Heidi; Drach, Mathias; Reichardt, Holger M.; Villunger, Andreas; Tischner, Denise; Wiegers, G. Jan: Glucocorticoid Receptor-Deficient Foxp3(+) Regulatory T Cells Fail to Control Experimental Inflammatory Bowel Disease.
    FRONTIERS IN IMMUNOLOGY. 2019; 10(S); 472.
    PubMed: 30936873 doi: 10.3389/fimmu.2019.00472 [FLDID: 126285] IF: 4.716 (2018) / ZIT: 4
  21. Sroczynski, Gaby; Esteban, Eva; Widschwendter, Andreas; Oberaigner, Wilhelm; Borena, Wegene; von Laer, Dorothee; Hackl, Monika; Endel, Gottfried; Siebert, Uwe: Reducing overtreatment associated with overdiagnosis in cervical cancer screening-A model-based benefit-harm analysis for Austria.
    INTERNATIONAL JOURNAL OF CANCER. 2019; [Epub ahead of print];
    PubMed: 31872420 doi: 10.1002/ijc.32849 [FLDID: 127484] IF: 4.982 (2018) / ZIT:
  22. Suciu, Ioan; Galeva, Slavyana; Abdel Azim, Samira; Pop, Lucian; Toader, Oana: First-trimester screening-biomarkers and cell-free DNA.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE. 2019; [Epub ahead of print];
    PubMed: 31766927 doi: 10.1080/14767058.2019.1698031 [FLDID: 127485] IF: 1.569 (2018) / ZIT:
  23. Vergote, I; du Bois, A.; Floquet, A.; Rau, J.; Kim, J-W; del Campo, J. M.; Friedlander, M.; Pignata, S.; Fujiwara, K.; Colombo, N.; Mirza, M. R.; Monk, B. J.; Tsibulak, I; Calvert, P. M.; Herzog, T. J.; Hanker, L. C.; Meunier, J.; Lee, J-Y; Bologna, A.; Carrasco-Alfonso, M. J.; Harter, P.: Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer.
    GYNECOLOGIC ONCOLOGY. 2019; 155(2); 186-191.
    PubMed: 31519320 doi: 10.1016/j.ygyno.2019.08.024 [FLDID: 127249] IF: 4.393 (2018) / ZIT: 1
  24. Vergote, Ignace; Coleman, Robert L.; Pignata, Sandro; Bookman, Michael A.; Marth, Christian; Herzog, Thomas J.; Martin, Antonio Gonzalez; Copeland, Larry J.; European Network Gynaecological; GOG Foundation Inc Grp: Joint ENGOT and GOG Foundation requirements for trials with industry partners.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019; 29(7); 1094-1097.
    PubMed: 31320391 doi: 10.1136/ijgc-2019-000441 [FLDID: 126865] IF: 1.746 (2018) / ZIT: 0
  25. Vergote, Ignace; Scambia, Giovanni; O'Malley, David M.; Van Calster, Ben; Park, Sang-Yoon; del Campo, Josep M.; Meier, Werner; Bamias, Aristotelis; Colombo, Nicofetta; Wenham, Robert M.; Covens, Al; Marth, Christian; Mirza, Mansoor Raza; Kroep, Judith R.; Ma, Haijun; Pickett, Cheryl A.; Monk, Bradley J.; TRINOVA-3 ENGOT-ov2 GOG-3001 Inves: Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.
    LANCET ONCOLOGY. 2019; 20(6); 862-876.
    PubMed: 31076365 doi: 10.1016/S1470-2045(19)30178-0 [FLDID: 126436] IF: 35.386 (2018) / ZIT: 4
  26. (κ) von Minckwitz, G.; Huang, CS.; Mano, MS.; Loibl, S.; Mamounas, EP.; Untch, M.; Wolmark, N.; Rastogi, P.; Schneeweiss, A.; Redondo, A.; Fischer, HH.; Jacot, W.; Conlin, AK.; Arce-Salinas, C.; Wapnir, IL.; Jackisch, C.; DiGiovanna, MP.; Fasching, PA.; Crown, JP.; Wülfing, P.; Shao, Z.; Rota Caremoli, E.; Wu, H.; Lam, LH.; Tesarowski, D.; Smitt, M.; Douthwaite, H.; Singel, SM.; Geyer, CE.; KATHERINE Investigators [Egle, D.; Hubalek, M.]: Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
    NEW ENGLAND JOURNAL OF MEDICINE. 2019; 380(7); 617-628.
    PubMed: 30516102 doi: 10.1056/NEJMoa1814017 [FLDID: 127505] IF: 70.670 (2018) / ZIT: 143
  27. (•) Widschwendter, Andreas; Boettcher, Bettina; Riedl, David; Coban, Serab; Mutz-Dehbalaie, Irene; Gothe, Raffaella Matteucci; Ciresa-Koenig, Alexandra; Marth, Christian; Fessler, Siegfried: Recurrence of genitals warts in pre-HPV vaccine era after laser treatment.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS. 2019; 300(3); 661-668.
    PubMed: 31286210 doi: 10.1007/s00404-019-05242-5 [FLDID: 126263] IF: 2.199 (2018) / ZIT: 0
  28. (•) Wieser, Verena; Sprung, Susanne; Tsibulak, Irina; Haybaeck, Johannes; Hackl, Hubert; Fiegl, Heidelinde; Marth, Christian; Zeimet, Alain Gustave: Clinical Impact of RANK Signalling in Ovarian Cancer.
    CANCERS. 2019; 11(6); 791.
    PubMed: 31181781 doi: 10.3390/cancers11060791 [FLDID: 126317] IF: 6.162 (2018) / ZIT: 0
  29. (•) Wieser, Verena; Tsibulak, Irina; Degasper, Christine; Welponer, Hannah; Leitner, Katharina; Parson, Walther; Zeimet, Alain G.; Marth, Christian; Fiegl, Heidelinde: Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer.
    CANCER SCIENCE. 2019; 110(3); 1117-1126.
    PubMed: 30697874 doi: 10.1111/cas.13955 [FLDID: 126726] IF: 4.751 (2018) / ZIT: 1
  30. (•) Marth, Christian; Wieser, Verena; Tsibulak, Irina; Zeimet, Alain G.: Immunotherapy in ovarian cancer: fake news or the real deal?
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019; 29(1); 201-211.
    PubMed: 30640705 doi: 10.1136/ijgc-2018-000011 [FLDID: 126185] IF: 1.746 (2018) / ZIT: 5
  31. Seeber, Beata; Böttcher, Bettina; D'Costa, Elisabeth; Wildt, Ludwig: Opioids and reproduction.
    VITAMINS AND HORMONES. 2019; 111; 247-279.
    PubMed: 31421703 doi: 10.1016/bs.vh.2019.07.001 [FLDID: 127486] IF: 2.494 (2018) / ZIT: 0
  32. (•) Tsibulak, Irina; Zeimet, Alain G.; Marth, Christian: Hopes and failures in front-line ovarian cancer therapy.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2019; 143(S); 14-19.
    PubMed: 31449982 doi: 10.1016/j.critrevonc.2019.08.002 [FLDID: 127366] IF: 5.012 (2018) / ZIT: 2
  33. (•) Kramer, Daniela; Stark, Nadine; Schulz-Heddergott, Ramona; Erytch, Norman; Edmunds, Shelley; Rossmann, Laura; Bastians, Holger; Concin, Nicole; Moll, Ute M.; Dobbelstein, Matthias: Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells (vol 24, pg 300, 2017).
    CELL DEATH AND DIFFERENTIATION. 2019; 26(4); 780-780.
    PubMed: 30177736 doi: 10.1038/s41418-018-0190-8 [FLDID: 126551] IF: 8.086 (2018) / ZIT: 0
  34. Vergote, Ignace; Coleman, Robert L.; Pignata, Sandro; Bookman, Michael A.; Marth, Christian; Herzog, Thomas J.; Gonzalez-Martin, Antonio; Copeland, Larry J.; European Network Gynaecologic; GOG Fdn Inc: Joint ENGOT and GOG Foundation requirements for trials with industry partners.
    GYNECOLOGIC ONCOLOGY. 2019; 154(2); 255-258.
    PubMed: 31331494 doi: 10.1016/j.ygyno.2019.04.677 [FLDID: 126120] IF: 4.393 (2018) / ZIT: 1
  35. Haslacher, Helmuth; Bayer, Michaela; Fiegl, Heidelinde; Gerner, Marlene; Hofer, Philipp; Korb, Melanie; Neururer, Sabrina; Perkmann, Thomas; Plattner, Katharina; Sargsyan, Karine; Steiner, Eberhard; Stumptner, Cornelia; Walter, Ingrid; Wieser, Monika; Wutte, Andrea; Wagner, Oswald; Zatloukal, Kurt: Quality management at the national biobanking level - establishing a culture of mutual trust and support: the BBMRI.at example.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2019; 57(12); E301-E305.
    PubMed: 31188755 doi: 10.1515/cclm-2019-0491 [FLDID: 127273] IF: 3.638 (2018) / ZIT: 0

<< zurück

Suche: © 2005 bis 2021, tirol kliniken